Lupin, Dr Reddy's Labs recall products in US over manufacturing issues: USFDA
New Delhi: Pharma majors Lupin, Dr Reddy's Laboratories are recalling products in the US over manufacturing issues, according to a latest enforcement report by the US Food and Drug Administration (USFDA).
The US-based arm of the Mumbai-based drug maker Lupin is recalling the 4,554 bottles of Cefixime for Oral Suspension, used to treat bacterial infections in the market, on account of it being "Subpotent".
According to PTI report, Baltimore-based Lupin Pharmaceuticals Inc. initiated the Class II recall on August 21.
As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Dr Reddy's Laboratories Inc, a subsidiary of Hyderabad-based drug firm, is recalling Ibuprofen tablets in multiple strengths, the US health regulator said in its latest enforcement report.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.